TFGT
ACAD icon

TS Financial Group (TSFG)’s Acadia Pharmaceuticals ACAD Stock Holding History

TS Financial Group (TSFG)’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-75
Closed -$2K – 841
2026
Q1 		$2K Hold
75
– – ﹤0.01% 723
2025
Q4 		$2K Hold
75
– – ﹤0.01% 721
2025
Q3 		$2K Hold
75
– – ﹤0.01% 725
2025
Q2 		$2K Hold
75
– – ﹤0.01% 703
2025
Q1 		$1K Buy
+75
New +$1.36K ﹤0.01% 736
2024
Q4 		– Sell
-72
Closed -$1K – 736
2024
Q3 		$1K Buy
+72
New +$1.2K ﹤0.01% 712

Other funds holding ACAD

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
WB
WesBanco Bank Wheeling, West Virginia $4.02B AUM 32.62% 1-Year Est. Return
SOADOR
State of Alaska Department of Revenue Juneau, Alaska $10.1B AUM 42.83% 1-Year Est. Return
PFC
Phocas Financial Corp Alameda, California $721M AUM 63.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LSERS
Louisiana State Employees Retirement System Baton Rouge, Louisiana $6.74B AUM 53.06% 1-Year Est. Return

TS Financial Group (TSFG)'s ACAD Position: Q2 2026 in Review

TS Financial Group (TSFG) sold out of Acadia Pharmaceuticals (ACAD) in Q2 2026, closing a stake of 75 shares — an estimated $2K sold.

TS Financial Group (TSFG) first reported a position in ACAD in Q3 2024 and held it in 6 quarters. The position peaked at $2K in Q1 2026. 82 funds tracked by Wall St. Rank hold ACAD as of Q2 2026.

  • TS Financial Group (TSFG) reported no remaining Acadia Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • TS Financial Group (TSFG) sold 75 Acadia Pharmaceuticals shares in Q2 2026, an estimated $2K.
  • TS Financial Group (TSFG) first reported a position in Acadia Pharmaceuticals in Q3 2024 and held it in 6 quarters.
  • TS Financial Group (TSFG)'s Acadia Pharmaceuticals position peaked at $2K in Q1 2026.
  • 82 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q2 2026.

Based on TS Financial Group (TSFG)'s 13F filing for Q2 2026, filed 23 Jul 2026.